PubMed HealthSearch

Biomedical subjects

J D Gresser

Publications and source records attributed to J D Gresser.

5 recordsLinked to original sources

Analysis of a vinyl pyrrolidone/poly(propylene fumarate) resorbable bone cement.

A resorbable bone cement was formulated from N-vinyl-2-pyrrolidinone (VP), the unsaturated polyester poly(propylene fumarate) (PPF), and the inorganic filler tribasic calcium phosphate (hydroxy apatite). Cure, initiated by benzoyl peroxide and accelerated by N,N-dimethyl-p-toluidine, resulted in the formation of VP crosslinks between polyester chains. During cure the cement hardened from a viscous moldable putty to a rigid structure with a shore D hardness of 50-60. The purpose of this study was to determine the fractions of PPF and VP incorporated into the crosslinked structure. Dissolution of the cured cement in water followed by extraction of the residue in tetrahydrofuran indicated that over 90% of the PPF was crosslinked over the range of PPF/VP ratios explored, but that the fraction of VP used in formation of crosslinks depended linearly on the PPF/VP ratio. Kinetic analysis of these data suggests that k'pp/kpf (the reactivity ratio) was approximately 2.0 where k'pp is the rate constant for the addition of VP radical to VP monomer leading to formation of poly(vinyl pyrrolidone), and kpf is for the addition of VP radical to PPF unsaturation.

Biocompatible Materials

Sustained-release characteristics of a new implantable formulation of disulfiram.

The object of this study was to evaluate the sustained-release characteristics of a new formulation of disulfiram. Solid rods (500 mg) made of a composite of 80% poly(glycolic-co-L-lactic acid) and 20% 14C-labeled disulfiram were implanted subcutaneously in five Wistar CD-1 rats; a control group received 100 mg of 14C-labeled disulfiram subcutaneously. Excretion of radiolabeled material in the urine and feces was monitored for 88 d. Sustained mobilization of drug was observed in the copolymer-disulfiram implant group, reaching a peak value 30 d after implantation. The control group exhibited first-order kinetics of drug mobilization. At necropsy, there was no encapsulation of the residual rods. The copolymer-disulfiram composite performed as a true sustained-release system, and improved formulations may have clinical applications in the treatment of alcoholic humans.

Animals